Gülmezoglu A M, Hofmeyr G J
Special Department of Research, Development and Research Training in Human Reproduction, UNDP/UNFPA/WHO/World Bank, World Health Organisation, Geneva 27, Switzerland, CH-1211.
Cochrane Database Syst Rev. 2000;1996(2):CD000167. doi: 10.1002/14651858.CD000167.
Failure of the normal expansion of plasma volume in the mother is associated with impaired fetal growth and pre-eclampsia.
The objective of this review was to assess the effects of plasma volume expansion for suspected impaired fetal growth.
We searched the Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register. Date of last search: December 1999.
Randomized or quasi-randomized trials of plasma volume expansion compared to no plasma volume expansion in women with suspected impaired fetal growth.
Trial quality was assessed.
No studies were included.
REVIEWER'S CONCLUSIONS: There is not enough evidence to evaluate the use of plasma volume expansion for suspected impaired fetal growth.
母亲血浆容量未能正常扩充与胎儿生长受限及先兆子痫有关。
本综述的目的是评估血浆容量扩充对疑似胎儿生长受限的影响。
我们检索了Cochrane妊娠与分娩组试验注册库和Cochrane对照试验注册库。末次检索日期:1999年12月。
对疑似胎儿生长受限的女性进行血浆容量扩充与不进行血浆容量扩充的随机或半随机试验。
评估试验质量。
未纳入任何研究。
尚无足够证据评估血浆容量扩充用于疑似胎儿生长受限的情况。